Ha habido 50 transacciones internas recientes registradas para Century Therapeutics, Inc. (IPSC), incluyendo 22 compras y 27 ventas. El total de compras internas fue valorado en $3.99M y el total de ventas internas en $300.89K.
Internos destacados con actividad reciente incluyen Cowan Chad, Carr Douglas, Russotti Gregory. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — IPSC
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Cowan Chad |
Chief Scientific Officer |
Retención Fiscal de RSU |
1,365 |
$2.19 |
$2.99K |
1,175,680 |
| 2026-03-12 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
7,043 |
$2.55 |
$17.95K |
507,261 |
| 2026-03-12 |
Russotti Gregory |
See Remarks |
Venta Informativa |
10,076 |
$2.55 |
$25.68K |
515,427 |
| 2026-03-11 |
Pfeiffenberger Brent |
President and CEO |
Retención Fiscal de RSU |
55,397 |
$2.73 |
$151.23K |
3,710,958 |
| 2026-03-11 |
Cowan Chad |
Chief Scientific Officer |
Retención Fiscal de RSU |
1,431 |
$2.73 |
$3.91K |
1,177,045 |
| 2026-03-09 |
Russotti Gregory |
See Remarks |
Venta Informativa |
479 |
$2.54 |
$1.21K |
525,503 |
| 2026-03-06 |
Pfeiffenberger Brent |
President and CEO |
Retención Fiscal de RSU |
463 |
$2.56 |
$1.19K |
3,766,355 |
| 2026-02-13 |
Pfeiffenberger Brent |
President and CEO |
Retención Fiscal de RSU |
31,172 |
$1.75 |
$54.55K |
3,766,818 |
| 2026-02-03 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
323 |
$1.82 |
$588.51 |
514,551 |
| 2026-02-02 |
Carr Douglas |
SVP Finance & Operations |
Concesión de RSU |
225,000 |
$1.84 |
$414K |
225,000 |
| 2026-02-02 |
Russotti Gregory |
See Remarks |
Concesión de RSU |
265,000 |
$1.84 |
$487.6K |
265,000 |
| 2026-02-02 |
Pfeiffenberger Brent |
President and CEO |
Concesión de RSU |
945,000 |
$1.84 |
$1.74M |
945,000 |
| 2026-02-02 |
Cowan Chad |
Chief Scientific Officer |
Concesión de RSU |
265,000 |
$1.84 |
$487.6K |
265,000 |
| 2026-01-02 |
Cowan Chad |
Chief Scientific Officer |
Retención Fiscal de RSU |
1,611 |
$1.00 |
$1.6K |
1,043,476 |
| 2025-12-22 |
Cowan Chad |
Chief Scientific Officer |
Compra Informativa |
58,060 |
$0.85 |
$49.25K |
1,045,087 |
| 2025-12-12 |
Pfeiffenberger Brent |
President and CEO |
Compra Informativa |
52,000 |
$0.58 |
$30.35K |
3,322,990 |
| 2025-12-10 |
Pfeiffenberger Brent |
President and CEO |
Retención Fiscal de RSU |
463 |
$0.53 |
$243.54 |
3,270,990 |
| 2025-12-09 |
Lee Han Myung |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-12-09 |
Lee Han Myung |
Director |
Concesión de RSU |
88,000 |
$0.59 |
$52.1K |
88,000 |
| 2025-12-08 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
257 |
$0.53 |
$136.72 |
404,874 |
| 2025-12-08 |
Russotti Gregory |
See Remarks |
Venta Informativa |
526 |
$0.53 |
$279.83 |
390,982 |
| 2025-11-20 |
Cowan Chad |
Chief Scientific Officer |
Venta Informativa |
5,462 |
$0.50 |
$2.74K |
987,027 |
| 2025-11-19 |
Pfeiffenberger Brent |
President and CEO |
Compra Informativa |
35,000 |
$0.50 |
$17.33K |
3,271,453 |
| 2025-11-17 |
Pfeiffenberger Brent |
President and CEO |
Venta Informativa |
32,456 |
$0.45 |
$14.74K |
3,236,453 |
| 2025-11-03 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
292 |
$0.59 |
$171.11 |
405,131 |
| 2025-09-18 |
Cowan Chad |
Chief Scientific Officer |
Concesión de RSU |
762,543 |
- |
- |
992,489 |
| 2025-09-08 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
263 |
$0.50 |
$131.50 |
405,423 |
| 2025-09-08 |
Russotti Gregory |
See Remarks |
Venta Informativa |
539 |
$0.50 |
$269.50 |
391,508 |
| 2025-09-08 |
Pfeiffenberger Brent |
President and CEO |
Venta Informativa |
488 |
$0.50 |
$244.00 |
3,268,909 |
| 2025-08-14 |
Pfeiffenberger Brent |
President and CEO |
Concesión de RSU |
1,587,614 |
- |
- |
3,269,397 |
| 2025-08-04 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
296 |
$0.53 |
$158.06 |
405,686 |
| 2025-06-12 |
Jimenez Joseph |
Director |
Concesión de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Butitta Cynthia M |
Director |
Concesión de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Walbert Timothy P |
Director |
Concesión de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Quimi Daphne |
Director |
Concesión de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Blackwell Kimberly |
Director |
Concesión de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Carlo Rizzuto |
Director |
Concesión de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-12 |
Riva Alessandro |
Director |
Concesión de RSU |
44,000 |
$0.60 |
$26.4K |
44,000 |
| 2025-06-09 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
4,904 |
$0.62 |
$3.05K |
405,982 |
| 2025-06-09 |
Russotti Gregory |
See Remarks |
Venta Informativa |
526 |
$0.62 |
$327.17 |
392,047 |
| 2025-06-09 |
Farid Adrienne |
Chief Operations Officer |
Venta Informativa |
552 |
$0.62 |
$343.34 |
250,141 |
| 2025-06-09 |
Pfeiffenberger Brent |
President and CEO |
Venta Informativa |
475 |
$0.62 |
$295.45 |
1,681,783 |
| 2025-05-16 |
Pfeiffenberger Brent |
President and CEO |
Venta Informativa |
29,552 |
$0.55 |
$16.14K |
1,682,258 |
| 2025-05-05 |
Carr Douglas |
SVP Finance & Operations |
Venta Informativa |
295 |
$0.55 |
$162.25 |
410,886 |
| 2025-05-05 |
Farid Adrienne |
Chief Operations Officer |
Venta Informativa |
1,024 |
$0.55 |
$563.20 |
250,693 |
| 2025-03-11 |
Carr Douglas |
SVP Finance & Operations |
Concesión de RSU |
95,625 |
$0.60 |
$57.47K |
95,625 |
| 2025-03-11 |
Russotti Gregory |
See Remarks |
Concesión de RSU |
120,000 |
$0.60 |
$72.12K |
120,000 |
| 2025-03-11 |
Farid Adrienne |
Chief Operations Officer |
Concesión de RSU |
120,000 |
$0.60 |
$72.12K |
120,000 |
| 2025-03-11 |
Conn Morgan |
Chief Finanical Officer |
Concesión de RSU |
19,500 |
$0.60 |
$11.72K |
19,500 |
| 2025-03-11 |
Pfeiffenberger Brent |
President and CEO |
Concesión de RSU |
521,500 |
$0.60 |
$313.42K |
521,500 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
